GIP (HUMAN)

GIP (HUMAN) Structure
CAS No.
100040-31-1
Chemical Name:
GIP (HUMAN)
Synonyms
GIP;GIP (HUMAN);GIP (Total);GIP (active);M.W. 4983.59 C226H338N60O66S;GASTRIC INHIBITORY PEPTIDE HUMAN;GASTRIC INHIBITORY POLYPEPTIDE (HUMAN);YAEGTFISDYSIAMDKIHQQDFVNWLLAQKGKKNDWKHNITQ;Gastric inhibitorypolypeptide (human) (9CI);Gastric inhibitory polypeptide human, ≥95% (HPLC)
CBNumber:
CB3381115
Molecular Formula:
C226H338N60O66S
Molecular Weight:
4983.52932
MOL File:
100040-31-1.mol
Modify Date:
2024/7/2 8:55:06

GIP (HUMAN) Properties

storage temp. −20°C
form Solid
color White to off-white
Water Solubility Soluble to 1 mg/ml in water
Sequence H-Tyr-Ala-Glu-Gly-Thr-Phe-Ile-Ser-Asp-Tyr-Ser-Ile-Ala-Met-Asp-Lys-Ile-His-Gln-Gln-Asp-Phe-Val-Asn-Trp-Leu-Leu-Ala-Gln-Lys-Gly-Lys-Lys-Asn-Asp-Trp-Lys-His-Asn-Ile-Thr-Gln-OH

SAFETY

Risk and Safety Statements

WGK Germany  3

GIP (HUMAN) price More Price(2)

Manufacturer Product number Product description CAS number Packaging Price Updated Buy
Sigma-Aldrich(India) G2269 Gastric Inhibitory Polypeptide human ≥95% (HPLC) 100040-31-1 0.1MG ₹21898.98 2022-06-14 Buy
Sigma-Aldrich(India) G2269 Gastric Inhibitory Polypeptide human ≥95% (HPLC) 100040-31-1 0.5MG ₹83569 2022-06-14 Buy
Product number Packaging Price Buy
G2269 0.1MG ₹21898.98 Buy
G2269 0.5MG ₹83569 Buy

GIP (HUMAN) Chemical Properties,Uses,Production

Description

GIP was originally isolated as a gastric inhibitory polypeptide. After the discovery of its glucose-dependent insulinotropic activity, known as the incretin effect, GIP was renamed glucose-dependent insulinotropic peptide.
Gastric inhibitory peptide
Abbreviation: GIP
Additional names: gastric inhibitory polypeptide,gastrointestinal inhibitory peptide, glucose-dependent, insulinotropic peptide

Chemical Properties

Human GIP: Mr 4983.6, theoretical pI 6.92. GIP is soluble in water, but insoluble in ethanol. GIP is inactivated by DPP-4.

History

GIP was originally isolated from the porcine intestinal extract on the basis of its acid inhibitory activity in dogs (gastric inhibitory polypeptide) in the early 1970s, and subsequently renamed glucose-dependent insulinotropic peptide after the finding of its physiologically important role as a potentiator of glucose-stimulated insulin secretion.

Uses

GIP possessing incretin activity enhances glucosestimulated insulin release. GIP agonists are potentially useful for the treatment of diabetes. Moreover, DPP-4 inhibitors are approved for use in diabetes patients because GIP is rapidly deactivated by DPP-4.

Biosynthesis

The expression of GIP is regulated by nutrients. The administration of glucose and lipid into the rat gastrointestinal tract increases GIP mRNA levels. Circulating GIP levels are low in the fasted state and increase within minutes of food ingestion. The postprandial levels of circulating GIP are dependent on meal size. The degree to which nutrients regulate GIP secretion is speciesdependent. Fat is a more potent stimulator than carbohydrates in humans, whereas in the rodent and pig, carbohydrates are more potent than fat. Once released, GIP is rapidly deactivated by DPP-4.

GIP (HUMAN) Preparation Products And Raw materials

Raw materials

Preparation Products

GIP (HUMAN) Suppliers

Global( 109)Suppliers
Supplier Tel Country ProdList Advantage Inquiry
Wuhan senwayer century chemical Co.,Ltd +undefined-27-86652399 +undefined13627115097 China 891 58 Inquiry
Alpha Biopharmaceuticals Co., Ltd +86-15542445688 China 888 58 Inquiry
Shenzhen Nexconn Pharmatechs Ltd +86-755-89396905 +86-15013857715 China 10318 58 Inquiry
BOC Sciences +1-631-485-4226 United States 19553 58 Inquiry
Shanghai Longyu Biotechnology Co., Ltd. +8613917842738 China 2534 58 Inquiry
Cellmano Biotech Limited 0551-65326643 18156095617 China 999 58 Inquiry
career henan chemical co +86-0371-86658258 +8613203830695 China 29826 58 Inquiry
Zhejiang J&C Biological Technology Co.,Limited +1-2135480471 +1-2135480471 China 10522 58 Inquiry
Alfa Chemistry United States 24072 58 Inquiry
Chengdu Youngshe Chemical Co., Ltd. +8618108235634 China 2345 58 Inquiry
H-TYR-ALA-GLU-GLY-THR-PHE-ILE-SER-ASP-TYR-SER-ILE-ALA-MET-ASP-LYS-ILE-HIS-GLN-GLN-ASP-PHE-VAL-ASN-TRP-LEU-LEU-ALA-GLN-LYS-GLY-LYS-LYS-ASN-ASP-TRP-LYS-HIS-ASN-ILE-THR-GLN-OH GLUCOSE-DEPENDENT INSULINOTROPIC POLYPEPTIDE (HUMAN) GASTRIC INHIBITORY PEPTIDE HUMAN GASTRIC INHIBITORY POLYPEPTIDE (HUMAN) GIP (HUMAN) GIP YAEGTFISDYSIAMDKIHQQDFVNWLLAQKGKKNDWKHNITQ TYR-ALA-GLU-GLY-THR-PHE-ILE-SER-ASP-TYR-SER-ILE-ALA-MET-ASP-LYS-ILE-HIS-GLN-GLN-ASP-PHE-VAL-ASN-TRP-LEU-LEU-ALA-GLN-LYS-GLY-LYS-LYS-ASN-ASP-TRP-LYS-HIS-ASN-ILE-THR-GLN Gastric Inhibitory Polypeptide (huMan) GIP (huMan), Glucose-Dependent Insulinotropic Polypeptide (huMan) GIP (huMan), Glucose-Dependent Insulinotropic Polypeptide (huMan) GIP, Tyr-Ala-Glu-Gly-Thr-Phe-Ile-Ser-Asp-Tyr-Ser-Ile-Ala-Met-Asp-Lys-Ile-His-Gln-Gln-Asp-Phe-Val-Asn-Trp-Leu-Leu-Ala-Gln-Lys-Gly-Lys-Lys-Asn-Asp-Trp-Lys-His-Asn-Ile-Thr-Gln M.W. 4983.59 C226H338N60O66S REF DUPL: H-Tyr-Ala-Glu-Gly-Thr-Phe-Ile-Ser-Asp-Tyr-Ser-Ile-Ala-Met-Asp-Lys-Ile-His-Gln-Gln-Asp-Phe-Val-Asn-Trp-Leu-Leu-Ala-Gln-Lys-Gly-Lys-Lys-Asn-Asp-Trp-Lys-His-Asn-Ile-Thr-Gln-OH Gastric inhibitorypolypeptide (human) (9CI) Gastric Inhibitory Polypeptide huManGastric Inhibitory Polypepti Gastric inhibitory polypeptide human, ≥95% (HPLC) GIP (active) GIP (Total) 100040-31-1 C226H338N60O66S Gastrointestinal Products Gastric Inhibitory Polypeptides Peptides Biochemicals and Reagents BioChemical Amino Acids and Peptides peptide Glucagon receptor and related